Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 75,812 | 329,534 | 246,773 | 158,813 | 70,700 |
| Depreciation Amortization | 30,531 | 130,794 | 98,963 | 64,988 | 32,925 |
| Income taxes - deferred | -5,742 | -68,358 | -25,368 | -16,873 | -9,261 |
| Accounts receivable | -13,802 | -24,841 | -10,661 | -8,479 | -4,769 |
| Accounts payable and accrued liabilities | 10,664 | -2,280 | 4,826 | 2,129 | 3,303 |
| Other Working Capital | 15,606 | 1,038 | 7,162 | -27,282 | -3,043 |
| Other Operating Activity | 38,585 | 166,056 | 90,507 | 63,830 | 6,700 |
| Operating Cash Flow | $151,654 | $531,943 | $412,202 | $237,126 | $96,555 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -773 | N/A | N/A | N/A | 0 |
| PPE Investments | -2,472 | -35,958 | -32,591 | -27,432 | -14,410 |
| Net Acquisitions | N/A | 33,703 | 33,703 | 33,703 | 32,703 |
| Purchase Sale Intangibles | -8,750 | N/A | N/A | N/A | 0 |
| Other Investing Activity | -8,750 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-11,995 | $-2,255 | $1,112 | $6,271 | $18,293 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 898,642 | 898,960 | 901,003 | N/A |
| Debt Repayment | -9,397 | -1,065,760 | -976,363 | -895,402 | -2,284 |
| Common Stock Issued | 3,780 | 40,523 | 34,025 | 26,730 | 13,504 |
| Common Stock Repurchased | -134,365 | -61,553 | -21,302 | -11,690 | -10,338 |
| Other Financing Activity | -12,476 | -26,175 | -25,782 | -16,679 | -4,143 |
| Financing Cash Flow | $-152,458 | $-214,323 | $-90,462 | $3,962 | $-3,261 |
| Exchange Rate Effect | 3,794 | -10,622 | -8,035 | -9,758 | -13,026 |
| Beginning Cash Position | 988,785 | 684,042 | 684,042 | 684,042 | 684,042 |
| End Cash Position | 979,780 | 988,785 | 998,859 | 921,643 | 782,603 |
| Net Cash Flow | $-9,005 | $304,743 | $314,817 | $237,601 | $98,561 |
| Free Cash Flow | |||||
| Operating Cash Flow | 151,654 | 531,943 | 412,202 | 237,126 | 96,555 |
| Capital Expenditure | -2,472 | -35,958 | -32,591 | N/A | -14,410 |
| Free Cash Flow | 149,182 | 495,985 | 379,611 | 237,126 | 82,145 |